About
Antibody drug conjugate
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibodySan Diego & Southern California
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
212
By Phase
PHASE1: 2
By Status
RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06710379Lead Sponsor
A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors
PHASE1Recruiting
68 participants
Started: Dec 30, 2024 · Completed: Dec 31, 2026
NCT06036121Lead Sponsor
A Study of ADRX-0706 in Select Advanced Solid Tumors
PHASE1Active, not recruiting
144 participants
Started: Sep 26, 2023 · Completed: Dec 31, 2026
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...